Mutations in DRP1 lead to several serious neurological disorders including epileptic encephalopathy (20–23) and optic atrophy (24), A truncating mutation in MFF was first described in a Saudi Arabian child with developmental delay, pyramidal signs, and neuropathy. Here, DNM1L is linked to optic atrophy.